Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden · Delayed Price · Currency is SEK 9.62
-0.26 (-2.63%)
At close: Dec 5, 2025
Diamyd Medical AB Market Cap
Diamyd Medical AB has a market cap or net worth of 1.32 billion as of December 5, 2025. Its market cap has increased by 2.98% in one year.
Market Cap
1.32B
Enterprise Value
1.05B
Revenue
130.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
9.62
Market Cap Chart
Since May 20, 2013, Diamyd Medical AB's market cap has increased from 132.51M to 1.32B, an increase of 898.19%. That is a compound annual growth rate of 20.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.32B | -22.70% |
| Dec 30, 2024 | 1.71B | 182.47% |
| Dec 29, 2023 | 605.80M | -41.10% |
| Dec 30, 2022 | 1.03B | -9.66% |
| Dec 30, 2021 | 1.14B | -46.65% |
| Dec 30, 2020 | 2.13B | 23.90% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 113.39B |
| Getinge AB | 57.22B |
| Sectra AB | 52.91B |
| Camurus AB | 35.47B |
| Medicover AB | 35.04B |
| Asker Healthcare Group AB | 34.47B |
| BioArctic AB | 27.14B |
| AddLife AB | 21.92B |